Mixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In Vivo
- 1 April 1998
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 8 (2) , 135-139
- https://doi.org/10.1089/oli.1.1998.8.135
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Antisense oligonucleotides: Is the glass half full or half empty?Biochemical Pharmacology, 1998
- Toxicologic Effects of an Oligodeoxynucleotide Phosphorothioate and Its Analogs Following Intravenous Administration in RatsAntisense and Nucleic Acid Drug Development, 1997
- Pattern and Kinetics of Cytokine Production Following Administration of Phosphorothioate Oligonucleotides in MiceAntisense and Nucleic Acid Drug Development, 1997
- Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studiesProceedings of the National Academy of Sciences, 1997
- In vivo studies with antisense oligonucleotidesTrends in Pharmacological Sciences, 1997
- Role of β-Chemokines in Suppressing HIV ReplicationScience, 1996
- A single-injection protein kinase A-directed antisense treatment to inhibit tumour growthNature Medicine, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Phosphorothioate Oligonucleotides Reduce Melanoma Growth in a SCID-hu Mouse Model by a Nonantisense MechanismAntisense Research and Development, 1995
- Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the MonkeyAntisense Research and Development, 1994